QUOTED. 26 October. Scott Rabuka.
Executive Summary
For the first time, the US FDA granted an emergency use authorization to a device that allows for the home collection of saliva for COVID-19 diagnosis. See what Scott Rabuka, senior director of molecular products at DNA Genotek, which developed the test, said about it here.
“Unlike samples collected with long, painful nasopharyngeal swabs, saliva samples are non-invasive and easy to collect with or without the supervision of a health care professional and can easily be sent to the lab for processing, allowing personnel and protective equipment to be saved for when they are most needed.” – Scott Rabuka, senior director of molecular products, DNA Genotek
- Find out more: COVID-19: Newly Authorized Device From OraSure Subsidiary Allows At-Home Collection Of Saliva Samples
Click here for a free trial of Medtech Insight